ABBV
Stock Details
ABBV is AbbVie Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 149.83$. Average daily volumn in 3 months 7.34M. Market cap 271.78B
Stock symbol : ABBV. Exchange : NYSE. Currency : USD Lastest price : 153.80$. Total volume : 4.62M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
AbbVie Inc. (ABBV)
Last Price
153.80$Change
0.64Volume
4.62M
| Previous Close | 153.16 |
| Open | 153.08 |
| Day Range | 151.46-153.86 |
| Bid | 153.41 x 1.3k |
| Ask | 156.70 x 900 |
| Volume | 4.62M |
| Average Volume | 7.34M |
| Market Cap | 271.78B |
| Beta | 0.81 |
| 52 Week Range | 105.56-175.91 |
| Trailing P/E | 22.07 |
| Foward P/E | 12.86 |
| Dividend (Yield %) | 3.67% |
| Ex-Dividend Date | 2022-07-14 |
Financial Details
Organization
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCL... EXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Market Cap:
271.78BRevenue:
56.2BTotal Assets:
146.53BTotal Cash:
9.75B
News about "AbbVie Inc."
AbbVie Inc. (NYSE:ABBV) Stake Lifted by Private Capital Group LLC
Source from : Defense World - 1 days ago
Private Capital Group LLC increased its position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 5.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the ...See details»
AbbVie Inc. (NYSE:ABBV) Holdings Increased by Cornerstone Wealth Management LLC
Source from : Defense World - 22 hours ago
Cornerstone Wealth Management LLC grew its stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 1.3% during the first quarter, according to its most recent filing with the Securities and ...See details»
Should You Consider Acquiring AbbVie (ABBV) Shares?
Source from : Yahoo! Sports - 1 days ago
Carillon Tower Advisers, an investment management firm, published its “Carillon Clarivest Capital Appreciation Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. At the ...See details»
When Abbvie Inc (ABBV) Moves Investors should Listen
Source from : news.stocktradersdaily - 1 days ago
When Abbvie Inc ABBV Moves Investors should Listen ...See details»
AbbVie Inc. (ABBV) Outlook: Revisiting The Past For Future Insights
Source from : stocksregister - 4 days ago
AbbVie Inc. (NYSE:ABBV) at last check was buoying at $152.49 on Thursday, June 30, with a fall of -1.07% from its closing price on previous day. Taking a look at stock we notice that its last check on ...See details»
Is AbbVie About To Get A New Blockbuster Drug?
Source from : Nasdaq - 8 days ago
L ast month, AbbVie submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for the compound ABBV-951 to treat motor fluctuations in patients with advanced ...See details»
Spire Wealth Management Reduces Position in AbbVie Inc. (NYSE:ABBV)
Source from : ETF Daily News - 6 days ago
Spire Wealth Management decreased its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 20.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 60,790 ...See details»
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
Source from : Nasdaq - 7 days ago
ABBV announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) has rendered a positive opinion on, and recommended granting approval to its JAK inhibitor ...See details»
Ritholtz Wealth Management Grows Stake in AbbVie Inc. (NYSE:ABBV)
Source from : ETF Daily News - 7 days ago
Ritholtz Wealth Management increased its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 279.3% in the first quarter, according to the company in its most recent filing with the Securities & ...See details»
AbbVie Stock’s Healthy Yield Makes it a High-Conviction Holding
Source from : YAHOO!Finance - 7 days ago
Headquartered in Illinois, AbbVie (NYSE:ABBV) is a well-respected pharmaceutical businesses with a broad range of medical treatments and solutions. If you’re going to pick a pharmaceutical-market ...See details»
AbbVie Rallies After Its Test of the Rising 200-Day Moving Average Line
Source from : TheStreet.com - 7 days ago
In this daily bar chart of , below, we can see that prices rallied back above the 50-day moving average line after touching/testing the rising 200-day line earlier this month. The ...See details»
Why AbbVie Stock Is Trading Higher Today
Source from : Benzinga.com - 13 days ago
AbbVie Inc (NYSE: ABBV) shares are trading higher Tuesday after the company announced it submitted a supplemental New Drug Application for atogepant to the U.S. Food and Drug Administration to support ...See details»
AbbVie Declares Quarterly Dividend
Source from : YAHOO!Finance - 11 days ago
The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.41 per share.See details»
Approximately 15,000 AbbVie Employees to Volunteer Globally to Support Local Communities in Annual Week of Possibilities
Source from : Business Insider - 7 days ago
AbbVie's Week of Possibilities returns in 2022 for its seventh year with approximately 15,000 employees participating in volunteer activities ...See details»